Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|5|2|96-114

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.5, Iss.2, 2010-05, pp. : 96-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients

By Alffenaar Jan-Willem C.  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global Control

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 73-91

Bentham Science Publishers

Access to resources Recommend Favorite

Comprehensive approach for extensively-drug resistant TB

By  

Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Treatment and Prevention of Multidrug-Resistant Tuberculosis

By Bastian I.   Colebunders R.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 633-661

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis

By Kumar Gaurav   Sharma Sadhna   Shafiq Nusrat   Pandhi Promila   Khuller Gopal Krishan   Malhotra Samir  

Drug Delivery, Vol. 18, Iss. 1, 2011-01 ,pp. : 65-73

Informa Healthcare

Access to resources Recommend Favorite